Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Janani Srinivasa Vasudevan"'
Autor:
Yogiraj Ray, Shekhar Ranjan Paul, Purbita Bandopadhyay, Ranit D’Rozario, Jafar Sarif, Deblina Raychaudhuri, Debaleena Bhowmik, Abhishake Lahiri, Janani Srinivasa Vasudevan, Ranjeet Maurya, Akshay Kanakan, Sachin Sharma, Manish Kumar, Praveen Singh, Rammohan Roy, Kausik Chaudhury, Rajsekhar Maiti, Saugata Bagchi, Ayan Maiti, Md. Masoom Perwez, Abhinandan Mondal, Avinash Tewari, Samik Mandal, Arpan Roy, Moumita Saha, Durba Biswas, Chikam Maiti, Ritwik Bhaduri, Sayantan Chakraborty, Biswanath Sharma Sarkar, Anima Haldar, Bibhuti Saha, Shantanu Sengupta, Rajesh Pandey, Shilpak Chatterjee, Prasun Bhattacharya, Sandip Paul, Dipyaman Ganguly
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-9 (2022)
Convalescent plasma therapy (CPT) is used to treat patients with Covid-19, but evidence for clinical benefit from clinical trials is divergent. Here the authors report in that CPT treatment does not affect mortality in patients with severe Covid-19 i
Externí odkaz:
https://doaj.org/article/61648fce8f2446988f7b6be76f0a7960
Autor:
Priti Devi, Ranjeet Maurya, Priyanka Mehta, Uzma Shamim, Aanchal Yadav, Partha Chattopadhyay, Akshay Kanakan, Kriti Khare, Janani Srinivasa Vasudevan, Shweta Sahni, Pallavi Mishra, Akansha Tyagi, Sujeet Jha, Sandeep Budhiraja, Bansidhar Tarai, Rajesh Pandey
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 3 (2022)
ABSTRACT The modulators of severe COVID-19 have emerged as the most intriguing features of SARS-CoV-2 pathogenesis. This is especially true as we are encountering variants of concern (VOC) with increased transmissibility and vaccination breakthroughs
Externí odkaz:
https://doaj.org/article/d43d2f66d77346129adfe6d38c4f3d93
Autor:
Shikha Bhat, Anuradha Pandey, Akshay Kanakan, Ranjeet Maurya, Janani Srinivasa Vasudevan, Priti Devi, Partha Chattopadhyay, Shimpa Sharma, Rajesh J. Khyalappa, Meghnad G. Joshi, Rajesh Pandey
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 11 (2021)
The global coronavirus disease 2019 (COVID-19) pandemic has demonstrated the range of disease severity and pathogen genomic diversity emanating from a singular virus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2). This diversity in dis
Externí odkaz:
https://doaj.org/article/a823a7f297b749a0ba0a939ab1c1c635
Autor:
Manoj Kumar, Sneha Gulati, Asgar H Ansari, Rhythm Phutela, Sundaram Acharya, Mohd Azhar, Jayaram Murthy, Poorti Kathpalia, Akshay Kanakan, Ranjeet Maurya, Janani Srinivasa Vasudevan, Aparna S, Rajesh Pandey, Souvik Maiti, Debojyoti Chakraborty
Publikováno v:
eLife, Vol 10 (2021)
The COVID-19 pandemic originating in the Wuhan province of China in late 2019 has impacted global health, causing increased mortality among elderly patients and individuals with comorbid conditions. During the passage of the virus through affected po
Externí odkaz:
https://doaj.org/article/f5788d259c3a4647be05cf2a2bbe03f3
Autor:
Jayanthi Shastri, Swapneil Parikh, Sachee Agrawal, Nirjhar Chatterjee, Manish Pathak, Sakshi Chaudhary, Chetan Sharma, Akshay Kanakan, Vivekanand A, Janani Srinivasa Vasudevan, Ranjeet Maurya, Saman Fatihi, Lipi Thukral, Anurag Agrawal, Lancelot Pinto, Rajesh Pandey, Sujatha Sunil
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Background: SARS-CoV-2 infection may not provide long lasting post-infection immunity. While hundreds of reinfections have reported only a few have been confirmed. Whole genome sequencing (WGS) of the viral isolates from the different episodes is man
Externí odkaz:
https://doaj.org/article/78e238a2ae6a46eb80aad0569362f322
Autor:
Priyanka Mehta, Shanmukh Alle, Anusha Chaturvedi, Aparna Swaminathan, Sheeba Saifi, Ranjeet Maurya, Partha Chattopadhyay, Priti Devi, Ruchi Chauhan, Akshay Kanakan, Janani Srinivasa Vasudevan, Ramanathan Sethuraman, Subramanian Chidambaram, Mashrin Srivastava, Avinash Chakravarthi, Johnny Jacob, Madhuri Namagiri, Varma Konala, Sujeet Jha, U. Deva Priyakumar, P. K. Vinod, Rajesh Pandey
Publikováno v:
Pathogens, Vol 10, Iss 9, p 1109 (2021)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) manifests a broad spectrum of clinical presentations, varying in severity from asymptomatic to mortality. As the viral infection spread, it evolved and developed into many variants of conce
Externí odkaz:
https://doaj.org/article/2b62036e88804736ad5d18a66adf1fa7
Autor:
Akshay Kanakan, Neha Mishra, Janani Srinivasa Vasudevan, Shweta Sahni, Azka Khan, Sachin Sharma, Rajesh Pandey
Publikováno v:
Pathogens, Vol 9, Iss 11, p 912 (2020)
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has challenged the research community globally to innovate, interact, and integrate findings across hierarchies. Research on SARS-CoV-2 has produced an abundance of data spanni
Externí odkaz:
https://doaj.org/article/b5849226743847cb9274df1e8f1f1b39
Autor:
Janani Srinivasa Vasudevan, Akshay Kanakan, Rajesh Pandey, Partha Chattopadhyay, Ranjeet Maurya
Publikováno v:
Briefings in Functional Genomics
Infectious diseases are potential drivers for human evolution, through a complex, continuous and dynamic interaction between the host and the pathogen/s. It is this dynamic interaction that contributes toward the clinical outcome of a pathogenic dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1808ab82cdba463bb9b780b956ead3eb
https://doi.org/10.1093/bfgp/elab037
https://doi.org/10.1093/bfgp/elab037
Autor:
Rajesh K. Pandey, Mohammed Masoom Perwez, Prasun Bhattacharya, Biswanath Sharma Sarkar, Shilpak Chatterjee, Rammohan Roy, Rajshekhar Maiti, Dipyaman Ganguly, Sachin Sharma, Abhishake Lahiri, Yogiraj Ray, Durba Biswas, Rahul Chakraborty, Saugata Bagchi, Bibhuti Saha, Ayan Maiti, Purbita Bandopadhyay, Shekhar Ranjan Paul, Kausik Chaudhuri, Sandip Paul, Chikam Maiti, Janani Srinivasa Vasudevan, Devlina Roy, Jafar Sarif, Ranit D'Rozario
Publikováno v:
The Journal of Infectious Diseases
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing coronavirus disease 2019 (COVID-19), has led to significant morbidity and mortality. While most suffer from mild symptoms, some patients progress to severe disease with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab50f59f4b4e5056e2e22d146d5680de
https://doi.org/10.1093/infdis/jiab010
https://doi.org/10.1093/infdis/jiab010
Autor:
Varma Konala, U. Deva Priyakumar, Madhuri Namagiri, Ramanathan Sethuraman, Subramanian Chidambaram, Sujeet Jha, Avinash Chakravarthi, Shanmukh Alle, Anusha Chaturvedi, Akshay Kanakan, Aparna Swaminathan, Partha Chattopadhyay, Sheeba Saifi, Ranjeet Maurya, Johnny Jacob, Ruchi Chauhan, Rajesh Pandey, P. K. Vinod, Janani Srinivasa Vasudevan, Priyanka Mehta, M. M. Srivastava, Priti Devi
Publikováno v:
Pathogens
Pathogens, Vol 10, Iss 1109, p 1109 (2021)
Volume 10
Issue 9
Pathogens, Vol 10, Iss 1109, p 1109 (2021)
Volume 10
Issue 9
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) manifests a broad spectrum of clinical presentations, varying in severity from asymptomatic to mortality. As the viral infection spread, it evolved and developed into many variants of conce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4574c42678569c27554bdb49faf44ec
http://europepmc.org/articles/PMC8464923
http://europepmc.org/articles/PMC8464923